Association of Interleukin 1 Family with Systemic Sclerosis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Inflammation

• Publication date

  2014-02-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10753-014-9848-7PMID 24531856
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of Interleukin-18 (-137G/C) Polymorphism with Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Meta-Analysis

  2014cited by this paper
• Serum levels of interleukin‐1α in patients with systemic sclerosis

  2013cited by this paper
• Overview of the interleukin-1 family of ligands and receptors.

  2013cited by this paper
• 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

  2013cited by this paper
• New Insights in the Immunobiology of IL-1 Family Members

  2013cited by this paper
• Biology of IL-36 cytokines and their role in disease.

  2013cited by this paper
• The interleukin-1 receptor family.

  2013influential reference
• 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

  2013cited by this paper
• The Role of the NLRP3 Inflammasome in Fibrosis

  2012cited by this paper
• Increased serum IL-33 levels may indicate vascular involvement in systemic sclerosis

  2012cited by this paper
• IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist

  2012cited by this paper
• IL-33

  2012cited by this paper
• N-Terminal Domain of Nuclear IL-1α Shows Structural Similarity to the C-Terminal Domain of Snf1 and Binds to the HAT/Core Module of the SAGA Complex

  2012cited by this paper
• Glucocorticoid Regulates Interleukin-37 in Systemic Lupus Erythematosus

  2012cited by this paper
• IL-37: a new anti-inflammatory cytokine of the IL-1 family.

  2011cited by this paper
• Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis

  2011cited by this paper
• Cytokine mRNA Profile of Alveolar T Lymphocytes and Macrophages in Patients with Systemic Sclerosis Suggests a Local Tr1 Response

  2011cited by this paper
• Interleukin-18: friend or foe for systemic sclerosis?

  2011cited by this paper
• Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement

  2011cited by this paper
• The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis.

  2011cited by this paper
• Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis.

  2010cited by this paper
• Epidemiology of systemic sclerosis.

  2010cited by this paper
• IL-18 downregulates collagen production in human dermal fibroblasts via the ERK pathway.

  2010cited by this paper
• The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis

  2009cited by this paper
• Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients.

  2008cited by this paper
• Interleukin-1 gene complex single nucleotide polymorphisms in systemic sclerosis: a further step ahead.

  2008cited by this paper
• Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma.

  2008cited by this paper
• Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis.

  2007cited by this paper
• Contribution of single nucleotide polymorphisms of the IL1A gene to the cleavage of precursor IL-1α and its transcription activity

  2007cited by this paper
• Interleukin-1 gene complex polymorphisms in systemic sclerosis patients with severe restrictive lung physiology.

  2007cited by this paper
• Contribution of single nucleotide polymorphisms of the IL1A gene to the cleavage of precursor IL-1alpha and its transcription activity.

  2007cited by this paper
• Novel functions of intracellular IL-1ra in human dermal fibroblasts: implications in the pathogenesis of fibrosis.

  2006cited by this paper
• Intracellular IL-1alpha-binding proteins contribute to biological functions of endogenous IL-1alpha in systemic sclerosis fibroblasts.

  2006cited by this paper
• Association between the interleukin-1 family gene cluster and psoriatic arthritis.

  2006cited by this paper
• Intracellular IL-1α-binding proteins contribute to biological functions of endogenous IL-1α in systemic sclerosis fibroblasts

  2006cited by this paper
• Classification of systemic sclerosis. Visions and reality.

  2005cited by this paper
• Interleukin 1alpha single-nucleotide polymorphism associated with systemic sclerosis.

  2004cited by this paper
• Autocrine activation by interleukin 1alpha induces the fibrogenic phenotype of systemic sclerosis fibroblasts.

  2004cited by this paper
• Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement

  2004cited by this paper
• Association of IL1A gene polymorphisms with susceptibility to and severity of systemic sclerosis in the Japanese population.

  2003cited by this paper
• A nuclear target for interleukin-1α: Interaction with the growth suppressor necdin modulates proliferation and collagen expression

  2003cited by this paper
• Proinflammatory cytokines (IL-12 and IL-18) in immune rheumatic diseases: relation with disease activity and autoantibodies production.

  2003cited by this paper
• Identification of an IL1A gene segment that determines aberrant constitutive expression of interleukin-1 alpha in systemic sclerosis.

  2003cited by this paper
• [A case of recurrent hemophagocytic syndrome complicated with systemic sclerosis: relationship between disease activity and serum level of IL-18].

  2001cited by this paper
• Endogenous IL-1α from systemic sclerosis fibroblasts induces IL-6 and PDGF-A

  1999cited by this paper
• Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A.

  1999cited by this paper
• Intracellular IL-1 receptor antagonist is elevated in human dermal fibroblasts that overexpress intracellular precursor IL-1 alpha.

  1999cited by this paper
• IL-1 rescues scleroderma myofibroblasts from serum-starvation-induced cell death.

  1999cited by this paper
• Increased production of nitric oxide stimulated by interleukin-1beta in peripheral blood mononuclear cells in patients with systemic sclerosis.

  1998cited by this paper
• IL‐lα gene expression and protein production by fibroblasts from patients with systemic sclerosis

  1994cited by this paper
• Classification of systemic sclerosis.

  1994cited by this paper
• Interleukin 1 Receptor on Fibroblasts from Systemic Sclerosis Patients Induces Excessive Functional Responses to Interleukin 1β

  1993cited by this paper
• Interleukin 1 receptor on fibroblasts from systemic sclerosis patients induces excessive functional responses to interleukin 1 beta.

  1993cited by this paper
• Increased interleukin 1 receptor, type I, at messenger RNA and protein level in skin fibroblasts from patients with systemic sclerosis.

  1992cited by this paper
• Production of intracellular and extracellular interleukin-1 alpha and interleukin-1 beta by peripheral blood monocytes from patients with connective tissue diseases.

  1991cited by this paper
• Enhanced production of interleukin-1 and tumor necrosis factor alpha by cultured peripheral blood monocytes from patients with scleroderma.

  1990cited by this paper
• Visions and reality

  1989cited by this paper
• Studies of an interleukin 1 inhibitor: characterization and clinical significance.

  1986cited by this paper
• Increased production of an interleukin 1 (IL-1) inhibitor with fibroblast stimulating activity by mononuclear cells from patients with scleroderma.

  1986cited by this paper
• Defective production of leucocytic endogenous mediator (interleukin 1) by peripheral blood leucocytes of patients with systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease.

  1986cited by this paper
• Spontaneous production of, and defective response to, interleukin-1 by peripheral blood mononuclear cells from patients with scleroderma.

  1985cited by this paper
• Interleukin-1 production by mononuclear cells from patients with scleroderma.

  1985cited by this paper

• Multinucleation and Apoptosis of Macrophages in BCG-Infected Mice and Production of Cathepsins and Matrix Metalloproteinases in These Cells

  2025cites this paper
• Investigation of multinucleation and apoptosis of macrophages of BCG-infected mice and their production of cathepsins and matrix metalloproteinases

  2024cites this paper
• Serum Levels of Selected IL-1 Family Cytokines in Patients with Morphea

  2022cites this paper
• Cathepsin B/NLRP3/GSDMD axis-mediated macrophage pyroptosis induces inflammation and fibrosis in systemic sclerosis.

  2022cites this paper
• The Anti-Fibrotic Effect of Cold Atmospheric Plasma on Localized Scleroderma In Vitro and In Vivo

  2021influential citation
• Immunobiological Properties and Clinical Applications of Interleukin-38 for Immune-Mediated Disorders: A Systematic Review Study

  2021cites this paper
• Innate immune response in systemic autoimmune diseases: a potential target of therapy

  2020cites this paper
• Analysis of serum interleukin(IL)‐1α, IL‐1β and IL‐18 in patients with systemic sclerosis

  2019influential citation
• Pirfenidone activates cannabinoid receptor 2 in a mouse model of bleomycin-induced pulmonary fibrosis

  2019cites this paper
• Systemic Sclerosis

  2019cites this paper
• The IL-1 family of cytokines and receptors in rheumatic diseases

  2019cites this paper
• IL-1 receptor blockade skews inflammation towards Th2 in a mouse model of systemic sclerosis

  2019cites this paper
• The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the in vivo Treatment of Immune-Related Diseases: A Systematic Review

  2018cites this paper
• Analysis of IL-1α, bFGF, TGF-β1, IFNγ, MMP-1, and CatD Expression in Multinuclea Macrophages In Vitro

  2018cites this paper
• MicroRNA-149 contributes to scarless wound healing by attenuating inflammatory response.

  2017cites this paper
• Clinical implications of the novel cytokine IL-38 expressed in lung adenocarcinoma: Possible association with PD-L1 expression

  2017cites this paper
• Regulation of fibroblast activity by keratinocytes, TGF-β and IL-1α Dedicated to my daughters Astrid and Matilda Örebro Studies in Medicine 133 ANITA KOSKELA VON SYDOW Regulation of fibroblast activity by keratinocytes, TGF-β and IL-1α

  2016cites this paper
• Innate Lymphoid Cells: A Promising New Regulator in Fibrotic Diseases

  2016cites this paper
• Serum levels of interleukin‐18‐binding protein isoform a: Clinical association with inflammation and pulmonary hypertension in systemic sclerosis

  2016cites this paper
• Association of interleukin-1 family cytokines single nucleotide polymorphisms with susceptibility to systemic sclerosis: an independent case–control study and a meta-analysis

  2016cites this paper
• Cytokines in the immunopathology of systemic sclerosis

  2015cites this paper
• Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis.

  2015cites this paper
• The potential role of IL‐33/ST2 signaling in fibrotic diseases

  2015cites this paper
• Systemic sclerosis: a critical digest of the recent literature.

  2015cites this paper
• The cytokines of pulmonary fibrosis: Much learned, much more to learn.

  2015cites this paper